Skip to main content
Londonlegal

Life

Health, medicine, wellness, beauty, nutrition, and organic living.

Read Novo's Disappointment with Former Pfizer Rival Drug

Novo's Disappointment with Former Pfizer Rival Drug

Novo Nordisk expresses disappointment with a drug it previously contested with Pfizer. Meanwhile, Revolution and Tango show encouraging cancer results, and Incyte acquires a bleeding disorder treatment.

Editorial Staff Jun 8